Cargando…

Difluoromethylornithine (DFMO) and Neuroblastoma: A Review

Neuroblastoma is a type of cancer that affects the sympathetic nervous system and is the most common extracranial solid tumor in children. Difluoromethylornithine (DFMO) is a drug that has shown promise as a treatment option for high-risk neuroblastoma. This review aims to provide an overview of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tangella, Adarsh Vardhan, Gajre, Ashwin S, Chirumamilla, Punith Chowdary, Rathhan, Pemma V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190116/ https://www.ncbi.nlm.nih.gov/pubmed/37206500 http://dx.doi.org/10.7759/cureus.37680

Ejemplares similares

Isocitrate Dehydrogenase 1 Mutation and Ivosidenib in Patients With Acute Myeloid Leukemia: A Comprehensive Review
por: Tangella, Adarsh Vardhan, et al.
Publicado: (2023)

Difluoromethylornithine (DFMO) and AMXT 1501 inhibit capsule biosynthesis in pneumococci
por: Ayoola, Moses B., et al.
Publicado: (2022)

Difluoromethylornithine (DFMO) Enhances the Cytotoxicity of PARP Inhibition in Ovarian Cancer Cells
por: El Naggar, Olivia, et al.
Publicado: (2022)

Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulindac for the prevention of sporadic colorectal adenomas
por: Zell, Jason A., et al.
Publicado: (2012)

Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas
por: Raj, K P, et al.
Publicado: (2013)

Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways
por: Alhosin, Mahmoud, et al.
Publicado: (2020)

Maintenance DFMO Increases Survival in High Risk Neuroblastoma
por: Sholler, Giselle L. Saulnier, et al.
Publicado: (2018)

Difluoromethylornithine (DFMO), an Inhibitor of Polyamine Biosynthesis, and Antioxidant N-Acetylcysteine Potentiate Immune Response in Mice to the Recombinant Hepatitis C Virus NS5B Protein
por: Lesnova, Ekaterina I., et al.
Publicado: (2021)

Imaging Modalities and Their Findings in Patients With Complex Regional Pain Syndrome: A Review
por: Tangella, Adarsh Vardhan
Publicado: (2023)

The Evolving Role of Intra-arterial Chemotherapy in Adult and Pediatric Cancers: A Comprehensive Review
por: Tangella, Adarsh Vardhan
Publicado: (2023)

A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma
por: Saulnier Sholler, Giselle L., et al.
Publicado: (2015)

Neuroendocrine Carcinoma of Cervix: A Case Series
por: Tangella, Adarsh Vardhan, et al.
Publicado: (2023)

DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27(Kip1) activity in neuroblastoma
por: KOOMOA, DANA-LYNN T., et al.
Publicado: (2013)

A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma
por: Lewis, Elizabeth C., et al.
Publicado: (2020)

A pilot study of genomic‐guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high‐risk neuroblastoma
por: Kraveka, Jacqueline M., et al.
Publicado: (2022)

Therapy of murine squamous cell carcinomas with 2-difluoromethylornithine
por: Chen, Yan, et al.
Publicado: (2004)

MDB-03. DFMO AS A TREATMENT STRATEGY IN GROUP 3 MEDULLOBLASTOMA
por: Shahab, Shubin, et al.
Publicado: (2023)

Difluoromethylornithine rebalances aberrant polyamine ratios in Snyder–Robinson syndrome
por: Stewart, Tracy Murray, et al.
Publicado: (2023)

Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas
por: Levin, Victor A, et al.
Publicado: (2018)

Anti-GD2 induced allodynia in rats can be reduced by pretreatment with DFMO
por: Diccianni, Mitchell B., et al.
Publicado: (2020)

ETMR-18. TARGETING Lin28 IN ETMR WITH ODC1 INHIBITOR DFMO
por: Goodyke, Austin, et al.
Publicado: (2020)

α-Difluoromethylornithine-Induced Cytostasis is Reversed by Exogenous Polyamines, Not by Thymidine Supplementation
por: Hyvönen, Mervi T., et al.
Publicado: (2021)

Choices and Challenges With Drug Therapy in Postural Orthostatic Tachycardia Syndrome: A Systematic Review
por: Vasavada, Advait M, et al.
Publicado: (2023)

Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats
por: Madka, Venkateshwar, et al.
Publicado: (2023)

Ethylene Diamine Tetra Acetate-Induced Pseudo Thrombocytopenia (EDTA-PTCP) in an Adolescent: A Case Report
por: Tangella, Adarsh Vardhan, et al.
Publicado: (2023)

Structural Insight into DFMO Resistant Ornithine Decarboxylase from Entamoeba histolytica: An Inkling to Adaptive Evolution
por: Preeti,, et al.
Publicado: (2013)

Induction and Prevention of Gastric Cancer with Combined Helicobacter Pylori and Capsaicin Administration and DFMO Treatment, Respectively
por: Aziz, Faisal, et al.
Publicado: (2020)

CLRM-14 INTRATUMORAL EXTRACELLULAR METABOLIC IMPACT OF DFMO AND AMXT 1501 IN LIVE HUMAN GLIOMAS
por: Riviere-Cazaux, Cecile, et al.
Publicado: (2022)

Metastasis of hormone-independent breast cancer to lung and bone is decreased by α-difluoromethylornithine treatment
por: Richert, Monica M, et al.
Publicado: (2005)

Use of Eflornithine (DFMO) in the Treatment of Early Alzheimer's Disease: A Compassionate Use, Single-Case Study
por: Alber, Jessica, et al.
Publicado: (2018)

The First Insight Into the Supramolecular System of D,L-α-Difluoromethylornithine: A New Antiviral Perspective
por: Bojarska, Joanna, et al.
Publicado: (2021)

A-11 | Burden And Impact Of Type 2 Myocardial Infarction-Related Hospitalizations and In-Hospital Mortality in Covid-19 Patients: A National Inpatient Sample Analysis, 2020
por: Borra, Vamsikalyan, et al.
Publicado: (2023)

A-40 | Dissecting Disparities of Post-Percutaneous Intervention Outcomes in Acute Myocardial Infarction Patients With COVID-19: Insights from National Inpatient Sample, 2020
por: Pingili, Adhvithi, et al.
Publicado: (2023)

DFMO Improves Survival and Increases Immune Cell Infiltration in Association with MYC Downregulation in the Pancreatic Tumor Microenvironment
por: Nakkina, Sai Preethi, et al.
Publicado: (2021)

Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer
por: Janakiram, Naveena B., et al.
Publicado: (2016)

Use of Balloon Occluded Retrograde Transvenous Obliteration (BRTO) for Treatment of Gastric Varices: A Narrative Review
por: Khakwani, Anum, et al.
Publicado: (2023)

The Polyamine Inhibitor Alpha-Difluoromethylornithine Modulates Hippocampus-Dependent Function after Single and Combined Injuries
por: Rosi, Susanna, et al.
Publicado: (2012)

Effect of an Inhibitor of Tumor Promotion, α‐Difluoromethylornithine, on Tumor Induction by Repeated Beta Irradiation in Mice
por: Ootsuyama, Akira, et al.
Publicado: (1993)

Immunosuppressive Microenvironment in Neuroblastoma
por: Pistoia, Vito, et al.
Publicado: (2013)

Difluoromethylornithine Is a Novel Inhibitor of Helicobacter pylori Growth, CagA Translocation, and Interleukin-8 Induction
por: Barry, Daniel P., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_spfe2oj8kr54oqcbuldv2qen9v